We are live on
!
Find out more
BCB
Brian C. Broderick Portfolio holdings
AUM
$542M
1-Year Est. Return
20.28%
This Fund
S&P 500
This Quarter
Est. Return
+0.43%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$375M
AUM Growth
-$1.83M
(-0.49%)
Cap. Flow
-$682K
Cap. Flow
% of AUM
-0.18%
Top 10 Holdings %
Top 10 Hldgs %
37.71%
Holding
82
New
2
Increased
18
Reduced
38
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$1.45M |
| 2 |
Honeywell
HON
|
+$1.03M |
| 3 |
Walt Disney
DIS
|
+$905K |
| 4 |
TJX Companies
TJX
|
+$843K |
| 5 |
Amazon
AMZN
|
+$821K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$1.24M |
| 2 |
Novartis
NVS
|
+$1.09M |
| 3 |
3M
MMM
|
+$1.08M |
| 4 |
Intel
INTC
|
+$1.06M |
| 5 |
Cisco
CSCO
|
+$973K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.31% |
| 2 | Technology | 20.11% |
| 3 | Industrials | 13.31% |
| 4 | Financials | 7.26% |
| 5 | Consumer Discretionary | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Coca-Cola
KO
$352B
| $597K | 0.16% |
11,380
-100
| -0.9% | -$5.57K |
|
|
NVO
52
Novo Nordisk
NVO
$217B
| $391K | 0.1% |
8,150
-400
| -5% | -$19.3K |
|
53
Aptiv
APTV
$12B
| $390K | 0.1% |
+2,618
| New | +$408K |
|
54
Cigna
CI
$76.1B
| $390K | 0.1% |
1,948
-100
| -5% | -$21.7K |
|
55
GE Aerospace
GE
$368B
| $351K | 0.09% |
5,465
-27
| -0.5% | -$1.74K |
|
56
Pfizer
PFE
$140B
| $307K | 0.08% |
7,154
| – | – |
|
57
Deere & Co
DE
$167B
| $305K | 0.08% |
910
-10
| -1% | -$3.6K |
|
58
Eli Lilly
LLY
$1.07T
| $303K | 0.08% |
1,307
-50
| -4% | -$12.3K |
|
59
NextEra Energy
NEE
$186B
| $299K | 0.08% |
3,800
| – | – |
|
60
Baxter International
BAX
$11.6B
| $290K | 0.08% |
3,600
-100
| -3% | -$7.9K |
|
61
ConocoPhillips
COP
$146B
| $276K | 0.07% |
4,084
| – | – |
|
62
McDonald's
MCD
$189B
| $265K | 0.07% |
1,100
| – | – |
|
63
IBM
IBM
$202B
| $249K | 0.07% |
1,880
| – | – |
|
64
General Mills
GIS
$19.1B
| $239K | 0.06% |
4,000
| – | – |
|
65
CSX Corp
CSX
$98.3B
| $232K | 0.06% |
7,800
-2,400
| -24% | -$76.8K |
|
66
Ingersoll Rand
IR
$33.1B
| $221K | 0.06% |
4,385
| – | – |
|
67
Dow Inc
DOW
$21.4B
| $219K | 0.06% |
3,822
| – | – |
|
68
Walmart Inc
WMT
$868B
| $216K | 0.06% |
4,650
| – | – |
|
69
Denali Therapeutics
DNLI
$3.66B
| $202K | 0.05% |
4,000
| – | – |
|
70
Cyclerion Therapeutics
CYCN
$15.6M
| $99K | 0.03% |
1,609
| – | – |
|
71
Annovis Bio
ANVS
$70.6M
| – | – |
-4,000
| Closed | -$342K |
|
72
International Flavors & Fragrances
IFF
$19.4B
| – | – |
-1,438
| Closed | -$215K |
|
Similar funds
MAM
WCA
ISB
CIAM
FMC
HCM
FSA
WW
Brian C. Broderick's Q3 2021 Portfolio in Review
As of Q3 2021, Brian C. Broderick held 82 positions worth $375M, down 0.49% from $376M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.9%. Brian C. Broderick opened 2 new positions and exited 2, leaving the 82-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Industrials.
- Brian C. Broderick's largest Q3 2021 buy was Edwards Lifesciences: 12,719 shares worth $1.44M.
- Brian C. Broderick added most to Honeywell in Q3 2021, an estimated $1.03M increase.
- Brian C. Broderick's biggest Q3 2021 reduction was Chubb, cutting an estimated $1.24M.
- Brian C. Broderick fully exited Annovis Bio in Q3 2021, selling an estimated $342K.
- Brian C. Broderick's ten largest holdings make up 38% of its $375M portfolio in Q3 2021.
- Brian C. Broderick opened 2 new positions and closed 2 in Q3 2021.
- Brian C. Broderick's portfolio value fell 0.49% quarter-over-quarter to $375M.
Based on Brian C. Broderick's 13F filing for Q3 2021, filed 10 Nov 2021.